|Day Low/High||30.48 / 30.59|
|52 Wk Low/High||29.89 / 35.13|
U.S. stocks are rising Monday as investors continue to digest comments from top Federal Reserve officials.
Roche (RHHBY) was given emergency approval by the FDA to issue its Zika diagnostics test which can be used to screen patients who have symptoms of the disease.
U.S. stock futures point lower and European stocks decline; Carl Icahn buys more Herbalife shares; FDA issues emergency use authorization for Roche Zika test.
U.S. stock futures are trading flat Monday as investors continue to digest comments from top Federal Reserve officials on Friday.
Automated workflows and integrated IT solutions that connect chemistry, coagulation and molecular diagnostics promise to deliver results to physicians faster, more reliably
HEAT-Seq Target Enrichment Systems help provide fast, accurate detection of human genetic variants
The first CLIA-waived, real-time PCR test that differentiates flu and RSV in 20 minutes is available now for use in physician offices and urgent care settings
The company sans CEO Scangos needs to do some type of deal in the coming months.
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III GOYA study evaluating Gazyva ® (obinutuzumab) plus CHOP chemotherapy (G-CHOP) in people with previously untreated...
Roche HPV test is first to be approved for use with the SurePath Preservative Fluid gynecologic cell collection medium commonly used for Pap tests
Juno Therapeutics reminds investors yet again that the business of biotech -- developing new medicines that are effective and reasonably safe -- is hard to get right.
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.
A sharp selloff in crude kept stocks mostly in the red, though optimism ahead of Friday's jobs reports kept losses to a minimum on Thursday.
The company's shares were up nearly 2% in after hours trading.
Great Britain's decision to leave the European Union may alter the way Europe does business, but U.S. investors should not view it as a complete game changer.
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.
First IVD company to provide a fully integrated solution for PCT testing with Elecsys BRAHMS PCT
While some say Sanofi could make a bid for BioMarin, analysts aren't so convinced.
Merck's flagship cancer immunotherapy Keytruda delayed the re-growth of tumors and prolonged survival in patients with newly diagnosed non-small cell lung cancer compared to chemotherapy, the company said Thursday.
A summary (and somewhat subjective) breakdown of winners and losers from the American Society of Clinical Oncology annual meeting.
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive results from the Phase III study known as GiACTA, which evaluated Actemra ® (tocilizumab) in people with giant cell...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that in a Phase II study, IMvigor 210, TECENTRIQ™ (atezolizumab) shrank tumors (objective response rate, ORR) in 24 percent (n=28)...
Test can be used with either plasma or tumor tissue, as a companion diagnostic for non-small cell lung cancer therapy
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) today announced positive results from the pivotal Phase III GALLIUM study in people with previously untreated follicular lymphoma, the most common type of...
New test standardizes CMV testing for both solid organ and hematopoietic stem cell transplant recipients
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that Alecensa ® (alectinib), an oral anaplastic lymphoma kinase (ALK) inhibitor, reduced the risk of disease worsening or death...
The VENTANA PD-L1 (SP142) Assay approved as a complementary diagnostic for TECENTRIQ™ (atezolizumab) immunotherapy